Clemens v. McNamee: Who’s Lying?
Key Takeaway Point from the original story: Why not reconnect with your country, and its people—the real America? Take an overnight train. You might even reconnect with yourself.
Big Pharma’s Many Phrauds
Last March we looked in on Big Pharma and listed the gazillions of dollars paid out in fines, lawsuits and the creation of reserve funds by the likes of Bristol-Myers Squibb ($839 million), GlaxoSmithKline ($150 million), Hoescht ($80 million), Eli Lilly and co. ($1.2 billion), Pfizer ($430 million) and Wyeth ($20 billion). Meanwhile winding their way through the courts are 1,400 lawsuits from Vioxx users, because the company withheld information about the possible “increased risk of cardiovascular events (including heart attack and stroke)” from the arthritis drug.
Business Common Sense: “The PR Disasters of Big Pharma”
To follow up, Merck & Co. is set to pay another $650 million to settle lawsuits for pricing fraud. –The Wall Street Journal, February 8, 2008: http://online.wsj.com/article/SB120239872627350891.html
On a widely disseminated TV commercial, artificial heart inventor Dr. Robert Jarvik proclaims: “When diet and exercise aren’t enough, adding Lipitor significantly lowers cholesterol.” It turns out that in the scene where Jarvik is seen rowing for exercise, it ain’t Jarvik. The ad agency hired a stunt man. Is this not fraud? —The New York Times, February 7, 2008: http://tinyurl.com/26btud
On February 14 came a report that Baxter International was importing an ingredient from a Chinese chemical company for its blood-thinning drug heparin that may have resulted in 350 allergic reactions including four deaths. —The Wall Street Journal, February 14, 2008: http://online.wsj.com/article/SB120293808086766253.html
One in every 10 patients admitted to six Massachusetts community hospitals suffered serious and avoidable medication mistakes. —The Boston Globe, February 14, 2008: http://tinyurl.com/33g86n
Last Sunday, “60 Minutes” ran a horrific report about Bayer’s Trasylol, used in operating rooms to control bleeding. The company suppressed reports for two years that the drug caused renal failure and continued to market it aggressively, causing an estimated 22,000 additional deaths over that two-year period. – “60 Minutes,” February 17, 2008: http://tinyurl.com/29ehe3